CMIC Holdings Co Ltd
TSE:2309
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CMIC Holdings Co Ltd
TSE:2309
|
JP |
|
S
|
Surat Textile Mills Ltd
BSE:530185
|
IN |
|
S
|
SalMar ASA
XBER:JEP
|
NO |
|
Andersons Inc
NASDAQ:ANDE
|
US |
|
B
|
Barrick Gold Corp
XHAM:ABR
|
CA |
|
C
|
Covivio Hotels SCA
LSE:0IS8
|
FR |
|
C
|
Clicks Group Ltd
JSE:CLS
|
ZA |
|
Petroreconcavo SA
BOVESPA:RECV3
|
BR |
|
B2Gold Corp
TSX:BTO
|
CA |
CMIC Holdings Co Ltd
CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.
CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. The company is headquartered in Minato-Ku, Tokyo-To and currently employs 5,569 full-time employees. The company went IPO on 2004-06-18. The Contract Research Organization (CRO) segment offers monitoring, data management, pharmaceutical consulting and nonclinical services. The Contract Manufacturing Organization (CMO) segment is engaged in the entrusted manufacture of drugs for pharmaceutical companies. The Contract Sales Organization (CSO) segment is engaged in the operation and marketing support for medicinal products. The Health Care segment conducts site support institute (SMO) business, and provides health care information services. The Intellectual Property Development (IPD) segment develops and sells diagnostic products and orphan drugs.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
